Fred Fleitz

Group Vice President, CMC at Arrowhead Pharmaceuticals

Speaker

Dr. Fleitz obtained his BS degree with a Chemistry major from Miami University in Oxford, Ohio. He then moved to Stanford University to pursue a Ph.D where his work included the development of palladium catalyzed reductive diyne cyclizations and the total synthesis of Siccanin. Dr. Fleitz then began his career at Merck and Co, in their Process Research department where he developed efficient, scaleable syntheses of small molecule drug candidates and was instrumental in the establishment of a biocatalysis group. After 14 years at Merck, Dr. Fleitz then moved to Cambridge Major Laboratories where his work again focused on the process development of small molecules. In June of 2010 Dr. Fleitz moved to Arrowhead Pharmaceuticals where he is currently the Senior Vice President, CMC and Developmental Chemistry.